The Banff 2022 Kidney Meeting Report: Reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics

Maarten Naesens, Candice Roufosse, Mark Haas, Carmen Lefaucheur, Roslyn B Mannon, Benjamin A Adam, Olivier Aubert, Georg A Böhmig, Jasper Callemeyn, Marian Clahsen-van Groningen, Lynn D Cornell, Anthony J Demetris, Cinthia B Drachenberg, Gunilla Einecke, Agnes B Fogo, Ian W Gibson, Philip Halloran, Luis G Hidalgo, Catherine Horsfield, Edmund HuangŽeljko Kikić, Nicolas Kozakowski, Brian Nankivell, Marion Rabant, Parmjeet Randhawa, Leonardo V Riella, Ruth Sapir-Pichhadze, Carrie Schinstock, Kim Solez, Anat R Tambur, Olivier Thaunat, Chris Wiebe, Dina Zielinski, Robert Colvin, Alexandre Loupy, Michael Mengel

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

The XVI-th Banff Meeting for Allograft Pathology was held at Banff, Alberta, Canada, from 19th to 23rd September 2022, as a joint meeting with the Canadian Society of Transplantation. To mark the 30th anniversary of the first Banff Classification, premeeting discussions were held on the past, present, and future of the Banff Classification. This report is a summary of the meeting highlights that were most important in terms of their effect on the Classification, including discussions around microvascular inflammation and biopsy-based transcript analysis for diagnosis. In a postmeeting survey, agreement was reached on the delineation of the following phenotypes: (1) "Probable antibody-mediated rejection (AMR)," which represents donor-specific antibodies (DSA)-positive cases with some histologic features of AMR but below current thresholds for a definitive AMR diagnosis; and (2) "Microvascular inflammation, DSA-negative and C4d-negative," a phenotype of unclear cause requiring further study, which represents cases with microvascular inflammation not explained by DSA. Although biopsy-based transcript diagnostics are considered promising and remain an integral part of the Banff Classification (limited to diagnosis of AMR), further work needs to be done to agree on the exact classifiers, thresholds, and clinical context of use.

Original languageEnglish (US)
JournalAmerican Journal of Transplantation
DOIs
StateE-pub ahead of print - Oct 28 2023

Fingerprint

Dive into the research topics of 'The Banff 2022 Kidney Meeting Report: Reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics'. Together they form a unique fingerprint.

Cite this